• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于个性化医学方法的基因人源化动物模型的使用。

The use of genetically humanized animal models for personalized medicine approaches.

机构信息

Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands

Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands.

出版信息

Dis Model Mech. 2019 Oct 1;13(2):dmm041673. doi: 10.1242/dmm.041673.

DOI:10.1242/dmm.041673
PMID:31591145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6906630/
Abstract

For many genetic diseases, researchers are developing personalized medicine approaches. These sometimes employ custom genetic interventions such as antisense-mediated exon skipping or genome editing, aiming to restore protein function in a mutation-specific manner. Animal models can facilitate the development of personalized medicine approaches; however, given that they target human mutations and therefore human genetic sequences, scientists rely on the availability of humanized animal models. Here, we outline the usefulness, caveats and potential of such models, using the example of the hDMDdel52/ model, a humanized model recently generated for Duchenne muscular dystrophy (DMD).

摘要

对于许多遗传疾病,研究人员正在开发个性化医疗方法。这些方法有时采用定制的基因干预措施,如反义介导的外显子跳跃或基因组编辑,旨在以突变特异性的方式恢复蛋白质功能。动物模型可以促进个性化医疗方法的发展;然而,由于它们针对的是人类突变,因此针对人类遗传序列,科学家们依赖于可获得的人源化动物模型。在这里,我们以最近为杜氏肌营养不良症(DMD)生成的人源化模型 hDMDdel52/ 为例,概述了此类模型的有用性、注意事项和潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2997/6906630/69c8df6a7eeb/dmm-13-041673-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2997/6906630/9376697ea7d0/dmm-13-041673-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2997/6906630/d89dd4ace5c7/dmm-13-041673-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2997/6906630/69c8df6a7eeb/dmm-13-041673-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2997/6906630/9376697ea7d0/dmm-13-041673-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2997/6906630/d89dd4ace5c7/dmm-13-041673-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2997/6906630/69c8df6a7eeb/dmm-13-041673-g3.jpg

相似文献

1
The use of genetically humanized animal models for personalized medicine approaches.用于个性化医学方法的基因人源化动物模型的使用。
Dis Model Mech. 2019 Oct 1;13(2):dmm041673. doi: 10.1242/dmm.041673.
2
Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model.详细的 hDMDdel52/mdx 小鼠模型的遗传和功能分析。
PLoS One. 2020 Dec 23;15(12):e0244215. doi: 10.1371/journal.pone.0244215. eCollection 2020.
3
Exon 51 Skipping Quantification by Digital Droplet PCR in del52hDMD/mdx Mice.通过数字液滴PCR对del52hDMD/mdx小鼠中外显子51跳跃进行定量分析
Methods Mol Biol. 2018;1828:249-262. doi: 10.1007/978-1-4939-8651-4_15.
4
Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.定量反义筛选和优化用于杜氏肌营养不良症外显子 51 跳跃。
Mol Ther. 2017 Nov 1;25(11):2561-2572. doi: 10.1016/j.ymthe.2017.07.014. Epub 2017 Jul 28.
5
Skipping multiple exons of dystrophin transcripts using cocktail antisense oligonucleotides.使用鸡尾酒反义寡核苷酸跳过肌营养不良蛋白转录本的多个外显子。
Nucleic Acid Ther. 2014 Feb;24(1):57-68. doi: 10.1089/nat.2013.0451. Epub 2013 Dec 31.
6
Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.反义介导的外显子跳跃对杜兴氏肌营养不良症突变的理论适用性。
Hum Mutat. 2009 Mar;30(3):293-9. doi: 10.1002/humu.20918.
7
Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy.靶向外显子跳跃作为杜氏肌营养不良症的一种潜在基因校正疗法。
Neuromuscul Disord. 2002 Oct;12 Suppl 1:S71-7. doi: 10.1016/s0960-8966(02)00086-x.
8
Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.将人类杜氏肌营养不良症(DMD)成纤维细胞直接重编程为肌管,用于体外评估反义介导的外显子跳跃以及外显子45 - 55跳跃并伴有肌营养不良蛋白表达恢复的情况。
Methods Mol Biol. 2018;1828:141-150. doi: 10.1007/978-1-4939-8651-4_8.
9
Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients?Duchenne 肌营养不良症无义突变的外显子跳跃:突变太多,患者太少?
Expert Opin Biol Ther. 2012 Sep;12(9):1141-52. doi: 10.1517/14712598.2012.693469. Epub 2012 Jun 1.
10
In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.反义磷酰二胺吗啉代寡聚物(PMO)在营养不良犬和7号外显子缺失的杜氏肌营养不良症(DMD)患者中诱导的体外多外显子跳跃
Methods Mol Biol. 2018;1828:151-163. doi: 10.1007/978-1-4939-8651-4_9.

引用本文的文献

1
The genetic secrets revealed from canine fetal fluids obtained in mid-pregnancy.孕中期获取的犬类胎液中揭示的遗传秘密。
Sci Rep. 2025 Aug 4;15(1):28375. doi: 10.1038/s41598-025-13183-0.
2
CRISPR-mediated megabase-scale transgene de-duplication to generate a functional single-copy full-length humanized DMD mouse model.CRISPR 介导的兆碱基规模转基因重复序列消除,以产生功能单拷贝全长人源化 DMD 小鼠模型。
BMC Biol. 2024 Sep 27;22(1):214. doi: 10.1186/s12915-024-02008-7.
3
A humanized knock-in mouse recapitulates a deep-intronic splice-activating variant.

本文引用的文献

1
Muscle biopsies in clinical trials for Duchenne muscular dystrophy - Patients' and caregivers' perspective.肌肉活检在杜氏肌营养不良症临床试验中的应用——患者和照护者的观点。
Neuromuscul Disord. 2019 Aug;29(8):576-584. doi: 10.1016/j.nmd.2019.06.004. Epub 2019 Jun 12.
2
Therapeutic developments for Duchenne muscular dystrophy.杜氏肌营养不良症的治疗进展。
Nat Rev Neurol. 2019 Jul;15(7):373-386. doi: 10.1038/s41582-019-0203-3.
3
International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases.
一只人源化敲入小鼠重现了一个内含子深处的剪接激活变体。
bioRxiv. 2024 Mar 22:2024.03.21.581572. doi: 10.1101/2024.03.21.581572.
4
The Evolution of Technology-Driven In Vitro Models for Neurodegenerative Diseases.用于神经退行性疾病的技术驱动体外模型的演变
Adv Sci (Weinh). 2024 Apr;11(16):e2304989. doi: 10.1002/advs.202304989. Epub 2024 Feb 17.
5
Duchenne muscular dystrophy: disease mechanism and therapeutic strategies.杜氏肌营养不良症:疾病机制与治疗策略。
Front Physiol. 2023 Jun 26;14:1183101. doi: 10.3389/fphys.2023.1183101. eCollection 2023.
6
CRISPR/Cas9-generated mouse model with humanizing single-base substitution in the for safety studies of RNA therapeutics.用于RNA疗法安全性研究的、在特定位置具有人源化单碱基替换的CRISPR/Cas9基因编辑小鼠模型。
Front Genome Ed. 2023 Apr 3;5:1034720. doi: 10.3389/fgeed.2023.1034720. eCollection 2023.
7
The predictive value of models of neuromuscular disorders to potentiate clinical translation.神经肌肉疾病模型对促进临床转化的预测价值。
Dis Model Mech. 2022 Jul 1;15(7). doi: 10.1242/dmm.049788. Epub 2022 Aug 1.
8
CRISPR applications for Duchenne muscular dystrophy: From animal models to potential therapies.CRISPR 在杜氏肌营养不良症中的应用:从动物模型到潜在疗法。
WIREs Mech Dis. 2023 Jan;15(1):e1580. doi: 10.1002/wsbm.1580. Epub 2022 Jul 31.
9
3D in vitro Models of Pathological Skeletal Muscle: Which Cells and Scaffolds to Elect?病理性骨骼肌的3D体外模型:选择哪些细胞和支架?
Front Bioeng Biotechnol. 2022 Jul 11;10:941623. doi: 10.3389/fbioe.2022.941623. eCollection 2022.
10
Evaluating Translational Methods for Personalized Medicine-A Scoping Review.评估个性化医疗的转化方法——一项范围综述
J Pers Med. 2022 Jul 19;12(7):1177. doi: 10.3390/jpm12071177.
国际合作行动和透明度,以了解、诊断和开发罕见病的治疗方法。
EMBO Mol Med. 2019 May;11(5). doi: 10.15252/emmm.201910486.
4
Natural disease history of the D2 mouse model for Duchenne muscular dystrophy.Duchenne 型肌营养不良症 D2 小鼠模型的自然病史。
FASEB J. 2019 Jul;33(7):8110-8124. doi: 10.1096/fj.201802488R. Epub 2019 Apr 1.
5
AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice.AAV CRISPR 编辑可挽救 18 个月大的肌肉营养不良症小鼠的心脏和肌肉功能。
JCI Insight. 2018 Dec 6;3(23):124297. doi: 10.1172/jci.insight.124297.
6
"Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic.“以鼠为尺”:一个推动杜氏肌营养不良症疗法进入临床应用的项目。
J Neuromuscul Dis. 2018;5(4):407-417. doi: 10.3233/JND-180324.
7
RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases.RD-Connect、NeurOmics 和 EURenOmics:协作的欧洲罕见病倡议。
Eur J Hum Genet. 2018 Jun;26(6):778-785. doi: 10.1038/s41431-018-0115-5. Epub 2018 Feb 27.
8
A dystrophic Duchenne mouse model for testing human antisense oligonucleotides.用于测试人类反义寡核苷酸的营养不良性杜氏肌营养不良症小鼠模型。
PLoS One. 2018 Feb 21;13(2):e0193289. doi: 10.1371/journal.pone.0193289. eCollection 2018.
9
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.杜氏肌营养不良的诊断和管理,第 2 部分:呼吸、心脏、骨骼健康和骨科管理。
Lancet Neurol. 2018 Apr;17(4):347-361. doi: 10.1016/S1474-4422(18)30025-5. Epub 2018 Feb 3.
10
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.杜氏肌营养不良症的诊断和管理,第 1 部分:诊断和神经肌肉、康复、内分泌、胃肠和营养管理。
Lancet Neurol. 2018 Mar;17(3):251-267. doi: 10.1016/S1474-4422(18)30024-3. Epub 2018 Feb 3.